lambrolizumab | Cafepharma

Markets That Can Propel Merck

Submitted by admin on Thu, 12/19/2013 - 17:12

Source

Forbes

Headline

Markets That Can Propel Merck

News Tags

5 Experimental Drugs That Could Make a Big Difference in Treating Lung Cancer

Submitted by admin on Sun, 09/22/2013 - 11:23

Source

Motley Fool

Headline

5 Experimental Drugs That Could Make a Big Difference in Treating Lung Cancer

News Tags

Peregrine Pharmaceuticals

Bristol-Myers Squibb

Clovis Oncology

What Does The FDA's Breakthrough Designation Mean For Investors?

Submitted by admin on Mon, 08/26/2013 - 13:28

Source

Seeking Alpha

Headline

What Does The FDA's Breakthrough Designation Mean For Investors?

Merck's Pipeline Of Drugs Should Make Up For Lost Sales To Generic Competition

Submitted by admin on Mon, 08/12/2013 - 09:11

Source

Seeking Alpha

Headline

Merck's Pipeline Of Drugs Should Make Up For Lost Sales To Generic Competition

News Tags

non-small cell lung cancer

Where Is Biotechnology's Next 'Anti-PD-1'?

Submitted by admin on Tue, 06/18/2013 - 09:50

Source

Seeking Alpha

Headline

Where Is Biotechnology's Next 'Anti-PD-1'?

News Tags

anti-PD-1 immunotherapy

Bristol-Myers Squibb

Baxter International

These 2 Health Care Stocks Could Win Big With FDA's New 'Breakthrough' Status

Submitted by admin on Fri, 06/14/2013 - 12:21

Source

Yahoo/Street Authority

Headline

These 2 Health Care Stocks Could Win Big With FDA's New 'Breakthrough' Status

News Tags

breakthrough therapies

Merck jumps on melanoma treatment results

Submitted by admin on Mon, 06/03/2013 - 11:26

Source

Marketwatch

Headline

Merck jumps on melanoma treatment results

News Tags

Bristol And Merck's Cancer Drugs Won ASCO. Five Slides Explain Why.

Submitted by admin on Mon, 06/03/2013 - 10:20

Source

TheStreet.com

Headline

Bristol And Merck's Cancer Drugs Won ASCO. Five Slides Explain Why.

News Tags

Bristol-Myers Squibb

Merck Rushes Forward In Race To Market Cell Death Cancer Drugs

Submitted by admin on Sun, 06/02/2013 - 11:56

Source

Forbes

Headline

Merck Rushes Forward In Race To Market Cell Death Cancer Drugs

News Tags

Merck's Novel Immunotherapy Drug Receives 'Breakthrough Therapy Designation'

Submitted by admin on Wed, 05/22/2013 - 09:35

Source

Seeking Alpha

Headline

Merck's Novel Immunotherapy Drug Receives 'Breakthrough Therapy Designation'

News Tags

breakthrough therapies

Subscribe to lambrolizumab